The Taxpayer Workforce Modernization Act (H.R. 7972) is a proposed law that aims to improve the Internal Revenue Service (IRS) by bringing in data science experts from the private sector. These experts would work alongside IRS tax specialists to tackle complex tax issues and enhance the agency's operations. The bill proposes creating a fellowship program to recruit at least 10 data scientists for terms of 2 to 4 years, with the possibility of permanent positions. Their tasks would include improving data collection, developing advanced analytics, and training IRS staff in data analysis techniques. The goal is to make the IRS more efficient and effective in serving taxpayers and enforcing tax laws.
Supporters of the Taxpayer Workforce Modernization Act highlight its potential to modernize the IRS by integrating private-sector data science expertise. Congressman David Schweikert, who introduced the bill, stated that it would help the IRS 'identify complex tax issues, improve customer service and make tax administration smarter, faster and more accountable.' The House Ways and Means Committee unanimously passed the bill, indicating bipartisan support for enhancing the IRS's capabilities through modernization efforts.
Critics of the Taxpayer Workforce Modernization Act express concerns about the effectiveness and implementation of the proposed fellowship program. They question whether the recruitment of private-sector data scientists will lead to meaningful improvements in tax administration or if it might divert resources from other critical areas. Additionally, there are apprehensions about the potential challenges in integrating external experts into the existing IRS workforce and whether the program's costs will justify its benefits.
While there are no direct industry overlaps between the sponsor David Schweikert's top donor industries and the subject matter of H.R. 7972, the Taxpayer Workforce Modernization Act, there is significant lobbying activity from health-related organizations. Schweikert's top donor industry, health professionals, contributed a substantial $1.8 billion, indicating a strong financial interest in health-related legislation. Additionally, the lobbying activity in this policy area includes contributions from various health-related companies, such as Stealth Biotherapeutics Inc. and Pharmaceutical Research and Manufacturers of America, totaling over $500,000. This raises concerns about potential influence on the bill's outcomes, even if no direct financial ties are evident between the donors and the bill itself.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA) | LMH STRATEGIC SOLUTIONS | $230,000 |
| STEALTH BIOTHERAPEUTICS INC. | LMH STRATEGIC SOLUTIONS | $60,000 |
| SAVARA INC. | LMH STRATEGIC SOLUTIONS | $60,000 |
| REGENXBIO INC. | LMH STRATEGIC SOLUTIONS | $60,000 |
| PTC THERAPEUTICS, INC. | LMH STRATEGIC SOLUTIONS | $50,000 |
| INCYTE CORPORATION | LMH STRATEGIC SOLUTIONS | $50,000 |
| HARMONY BIOSCIENCES | LMH STRATEGIC SOLUTIONS | $50,000 |
| GLAXOSMITHKLINE LLC | LMH STRATEGIC SOLUTIONS | $50,000 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | LMH STRATEGIC SOLUTIONS | $30,000 |
| NEUROPACE, INC. | LMH STRATEGIC SOLUTIONS | $30,000 |
| IONIS PHARMACEUTICALS, INC. | LMH STRATEGIC SOLUTIONS | $30,000 |
| ERISA INDUSTRY COMMITTEE (ERIC) | LMH STRATEGIC SOLUTIONS | $30,000 |
| UNIVERSITY OF LOUISVILLE HEALTH | LMH STRATEGIC SOLUTIONS | $20,000 |
| NATERA, INC. | LMH STRATEGIC SOLUTIONS | $20,000 |
| MEDICAL DEVICE MANUFACTURERS ASSOCIATION | LMH STRATEGIC SOLUTIONS | $20,000 |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding David Schweikert, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
